LifeStance Health Group Inc (LFST) Shares Up Despite Recent Market Volatility

LifeStance Health Group Inc (NASDAQ: LFST)’s stock price has increased by 1.00 compared to its previous closing price of 5.99. However, the company has seen a 1.68% increase in its stock price over the last five trading sessions. Seeking Alpha reported 2024-02-28 that LifeStance Health Group, Inc. (LFST) Q4 2023 Earnings Call Transcript

Is It Worth Investing in LifeStance Health Group Inc (NASDAQ: LFST) Right Now?

LFST has 36-month beta value of 1.33. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for LFST is 84.31M, and currently, short sellers hold a 24.65% ratio of that float. The average trading volume of LFST on April 04, 2024 was 1.39M shares.

LFST’s Market Performance

LFST stock saw a decrease of 1.68% in the past week, with a monthly decline of -22.04% and a quarterly a decrease of -23.42%. The volatility ratio for the week is 4.30%, and the volatility levels for the last 30 days are 4.29% for LifeStance Health Group Inc (LFST). The simple moving average for the last 20 days is -6.62% for LFST stock, with a simple moving average of -15.98% for the last 200 days.

Analysts’ Opinion of LFST

Many brokerage firms have already submitted their reports for LFST stocks, with Barclays repeating the rating for LFST by listing it as a “Underweight.” The predicted price for LFST in the upcoming period, according to Barclays is $7 based on the research report published on January 03, 2024 of the current year 2024.

TD Cowen, on the other hand, stated in their research note that they expect to see LFST reach a price target of $9, previously predicting the price at $8. The rating they have provided for LFST stocks is “Market Perform” according to the report published on May 15th, 2023.

Morgan Stanley gave a rating of “Overweight” to LFST, setting the target price at $8 in the report published on January 06th of the previous year.

LFST Trading at -8.21% from the 50-Day Moving Average

After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.91% of loss for the given period.

Volatility was left at 4.29%, however, over the last 30 days, the volatility rate increased by 4.30%, as shares sank -18.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.43% lower at present.

During the last 5 trading sessions, LFST rose by +1.68%, which changed the moving average for the period of 200-days by -33.88% in comparison to the 20-day moving average, which settled at $6.41. In addition, LifeStance Health Group Inc saw -22.73% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at LFST starting from Burdick Kenneth A, who sale 214,605 shares at the price of $6.28 back on Mar 15 ’24. After this action, Burdick Kenneth A now owns 2,934,372 shares of LifeStance Health Group Inc, valued at $1,347,719 using the latest closing price.

Mullins Kevin Michael, the Chief Development Officer of LifeStance Health Group Inc, sale 44,540 shares at $6.33 during a trade that took place back on Mar 14 ’24, which means that Mullins Kevin Michael is holding 4,745,352 shares at $281,938 based on the most recent closing price.

Stock Fundamentals for LFST

Current profitability levels for the company are sitting at:

  • -0.18 for the present operating margin
  • 0.27 for the gross margin

The net margin for LifeStance Health Group Inc stands at -0.18. The total capital return value is set at -0.09. Equity return is now at value -12.64, with -8.23 for asset returns.

Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -0.05. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -8.87.

Currently, EBITDA for the company is -106.91 million with net debt to EBITDA at -4.01. When we switch over and look at the enterprise to sales, we see a ratio of 2.59. The receivables turnover for the company is 8.4for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.11.


To put it simply, LifeStance Health Group Inc (LFST) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts